No Data
Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Prospects Need A Boost To Lift Shares
Shinva Medical Instrument (600587.SH): plans to acquire a 36.19% stake in Zhongzhi Biological.
Glonghui reported on December 30 that Shinva Medical Instrument (600587.SH) announced plans to acquire Wuhan Zhongzhi Biotechnology Co., Ltd. (referred to as "Zhongzhi Biotechnology", stock code: 836) from Shenzhen Meijian Electronic Technology Development Co., Ltd., Shenzhen Meikang Information Technology Development Co., Ltd., individuals Ding Yeqing, Wang Zhanbao, Shanghai Shengyu Heike Venture Capital Center (Limited Partnership), individuals Lian Qiming, Zhuang Jinhui, Dong Yan, Liu Weibo, and Shenzhen Xipeng Private Equity Partnership (Limited Partnership) for a price of 166.4792 million RMB.
Shinva Medical Instrument Gets Medical Device Registration for Cleaning, Disinfecting Device
Shinva Medical Instrument Gets Nod to Register Disposable Hemodialysis Tubing
China Post Securities: The old-for-new policy has entered the implementation phase, and the medical devices sector is expected to enter a period of high performance growth.
It is expected that in December and the first quarter of 2025, various provinces will gradually implement the trade-in policy, relevant hospital tenders will be initiated, and equipment manufacturers are expected to see a large number of trade-in orders in the fourth quarter.
Shinva Medical InstrumentLtd (SHSE:600587) Is Looking To Continue Growing Its Returns On Capital
Shinva Medical InstrumentLtd (SHSE:600587) May Have Issues Allocating Its Capital
